The-14Jul 28, 2025
Canada’s new drug pricing guidelines are industry-friendly
#Canada #Health #Pharmacare #DrugPrices #CanadaHealth #PMPRB #HealthPolicy #AffordableMeds #PrescriptionCosts #BigPharma #HealthEquity #PublicHealth #DrugPrices #PrescriptionDrugs
https://the-14.com/canadas-new-drug-pricing-guidelines-are-industry-friendly/
Vicky SmithMay 3, 2023

Big pharma has too much sway over Canada’s drug pricing, ex-review board members say

"Matthew Herder, who quit the Patented Medicine Prices Review Board in February, blasted drug companies for 'playing fast and loose with the facts about the Trudeau government’s long-promised drug pricing reforms."

https://www.ipolitics.ca/news/big-pharma-has-too-much-sway-over-canadas-drug-pricing-ex-review-board-members-say

#Canada #BigPharma #PMPRB #CdnPoli

Big pharma has too much sway over Canada’s drug pricing, ex-review board members say

Matthew Herder, who quit the Patented Medicine Prices Review Board in February, blasted drug companies for “playing fast and loose with the facts” about the Trudeau government’s long-promised drug pricing reforms.

Franke JamesFeb 23, 2023

Member of Canada’s drug pricing regulator quits over ‘lack of support’ for medicine cost reforms:
"Herder, director of Dalhousie Univ's Health Law Inst & an associate prof, Dept of Pharmacology and Schulich School of Law, said the govt has “fundamentally undermined” the board’s independence and credibility.

"He said despite the #PMPRB’s mandate to protect consumers from “excessive” drug prices, patented medicine prices in #Canada remain among the highest in the world."
https://globalnews.ca/news/9506406/pmprb-member-resigns-reforms-failure/

Member of Canada’s drug pricing regulator quits over ‘lack of support’ to lower medicine costs

A member of the Patented Medicine Prices Review Board has resigned over what he calls a 'lack of support' from the federal government and failure to implement reforms.

Global News